Judges Scientific (JSCIF) AI Stock Analysis

1 Followers

Judges Scientific

(Other OTC:JSCIF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Acquisition-led compoundingThe acquisition model has produced sustained revenue and EBIT growth across two decades, while organic expansion shows the portfolio can develop beyond deal activity. A deep pipeline and established operating approach support continued compounding potential over the next several years.

Negative Factors

Sharp earnings deteriorationThe sharp first-half contraction shows that Judges Scientific's high-margin businesses have significant operating leverage, making earnings vulnerable when equipment demand weakens. A heavily weighted second half leaves profitability dependent on recovery and successful delivery over the coming months.

Judges Scientific (JSCIF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $236.12M
Dividend Yield: 3.64%
Average Volume (3M): 2,678
Price to Earnings (P/E): -405.6
Beta (1Y): -1.10
Revenue Growth: -4.78%
EPS Growth: -105.68%
Country: US
Employees: 791
Sector: Technology
Sector Strength: 61
Industry: Hardware, Equipment & Parts

Judges Scientific Business Overview & Revenue Model

Company Description

Judges Scientific plc is a company dedicated to the design, production, and worldwide sale of advanced scientific instruments. Its operations are structured around two core divisions: Materials Sciences and Vacuum. The company provides a wide array o...

Judges Scientific Earnings Call Summary

Earnings Call Date:Sep 23, 2026(Q2-2026)|% Change Since:-15.48%|Next Earnings Date:Mar 24, 2027

Earnings Call SentimentNeutral

The call presented a sharply weaker first-half financial performance, with revenue down 21%, adjusted earnings per share down 72%, lower operating profit, increased gearing and depressed ROTIC. However, management highlighted improving order intake from down 18% in Q1 to down 1% year-to-date, strong cash conversion, a 10% dividend increase, progress in underperforming businesses, industrial-market opportunities, a healthy acquisition pipeline and reaffirmed full-year guidance. The positive operational momentum and confidence were offset by significant research-funding, China, offshore-wind and execution headwinds, resulting in a balanced overall tone.

Positive Updates

Order Intake Momentum Improved

Like-for-like order intake improved from down 18% in Q1 to down 12% at the end of H1 and was just 1% down year-to-date at the end of the week before the presentation. The last four months of orders had been at or around the internal budget level for at least a month, supporting management's confidence in the order book and full-year delivery.

Negative Updates

Sharp H1 Revenue Decline

Total H1 revenue declined 21% year over year, or 13% on a like-for-like basis after excluding the Geotek coring expedition in H1 2025 that was known not to recur.

Company Guidance

The group is guiding trading in line with FY 2026 market expectations, supported by Q3 order intake in line with expectations, like-for-like order intake year-to-date at almost parity and an improved order book, although revenue will have a significant H2 weighting, indeed a Q4 weighting, with execution risks. Meeting market expectations requires delivering GBP 1.60 in the second half, aided by a lower cost base in H2 this year compared to last year, the Patent Box benefit and operating leverage on higher volumes; the effective rate of tax expected for this year is 18%. The group expects continued headwinds in scientific research, including continued challenges around U.S. federal funding research into 2027, while the next Geotek coring expedition is not now expected earlier than 2028. The total annual dividend policy remains to increase by a minimum 10% annually, and the interim dividend was increased by 10% to GBP 0.36 per share.

Judges Scientific Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

JSCIF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:RSW	78Outperform	GBP 3.61B	29.71	12.53%	1.56%	14.41%	41.98%
GB:DSCV	69Neutral	GBP 779.54M	26.27	9.04%	1.65%	4.82%	17.80%
GB:TTG	63Neutral	GBP 321.94M	-8.99	-24.38%	―	-2.68%	47.33%
Sector *	61Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
GB:KMK	53Neutral	GBP 35.39M	48.18	1.32%	―	2.30%	-81.36%

* Technology Sector Average

Performance Comparison

JSCIF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JSCIF	Judges Scientific	43.60	-21.32	-32.84%
GB:KMK	Kromek Group plc	5.30	-1.60	-23.19%
GB:RSW	Renishaw plc	4872.00	1610.89	49.40%
GB:TTG	TT Electronics	180.00	38.40	27.12%
GB:DSCV	Discoverie Group	788.00	230.17	41.26%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Judges Scientific AI Stock Analysis